GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
companies in this sector in UNITED STATES :
sales of $42.06 billion
of which 68%
of which 78%
was Innovative Medicines), and
Merck & Co. , Inc.
of which 89%
was Merck Pharmaceutical).
During the year ended December of 2019, sales at
GlaxoSmithKline plc were $43.18 billion.
increase of 5.3%
versus 2018, when the company's sales were $41.01 billion.
This was the fourth straight year of sales growth at GlaxoSmithKline plc.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
16.7% in 2019, from
$7.84 billion to $9.15 billion.
GlaxoSmithKline plc also saw significant increases in sales in
Consumer Healthcare (up 12.9% to $11.51 billion)
Not all segments of GlaxoSmithKline plc experienced an increase in sales in 2019:
sales of Pharmaceuticals fell 2.3% to $22.45 billion.